Bayer (BAY) Climate Transition Analysis

Emissions, Petrochemicals, Chemicals

A new analysis of German multinational pharmaceutical and biotechnology company Bayer finds that the company shows extremely modest plans to reduce its Scope 3 emissions, despite these accounting for over three quarters of its emissions. Although the company is committed to ambitious climate targets, including to become Net Zero by 2050 across its entire value chain, there is no roadmap for investors to show how it will achieve this.

UPDATE: By July 2024, Bayer provided additional data showing positive changes in the company’s climate transition plans.

Related Content

The latest reports to your inbox

Don’t miss out! To receive Planet Tracker's reports just click below and complete the contact form.

Sign up